ATryn is the brand name of the anticoagulant antithrombin manufactured by the Massachusetts-based U.S. company GTC Biotherapeutics. It is made from the milk of goats that have been genetically modified to produce human antithrombin, a plasma protein with anticoagulant properties. Microinjection was used to insert human antithrombin genes into the cell nucleus of their embryos. ATryn is the first medicine produced using genetically engineered animals. GTC states that one genetically modified goat can produce the same amount of antithrombin in a year as 90,000 blood donations. GTC chose goats for the process because they reproduce more rapidly than cattle and produce more protein than rabbits or mice.

More on Wikipedia

Brand name: Atryn
Generic name/category: anticoagulant antithrombin, Anticoagulants, Genetic engineering
Company: Lundbeck
Country/Market: USA, North America
Indication(s)/use: prevention of peri-operative and peri-partum thromboembolic events
Target: Healthcare Professionals (HCP)
Tagline: Make a recombinant connection
Medium: Print ad
Size/duration: single-page
Publication/Aired: Blood – August 06, 2009
1 views
Sep 17, 2009

Visit AdPharm.net for more pharmaceutical ads

Take IV iron therapy to a proven place:
Response with toleration!

The only first-line IV iron for pre-dialysis CKD patients…

Venofer (iron sucrose injection) is a complex of polynuclear iron (III)-hydroxide in sucrose. It is approved for use in replenishing iron in patients receiving erythropoietin (a hormone that stimulates red blood cell production) and undergoing chronic hemodialysis, which involves filtering the blood in order to remove waste products. In these patients, an iron deficiency is caused by blood loss during the dialysis procedure, increased erythropoiesis (red blood cell production), and insufficient absorption of iron from the gastrointestinal tract. Iron is essential for the synthesis of hemoglobin, which is responsible for the transport of oxygen throughout the body.

More on Medilexicon

Brand name: Venofer
Generic name/category: iron sucrose injection
Company: American Regent
Country/Market: USA, North America
Indication(s)/use: replenishing iron in patients receiving erythropoietin (a hormone that stimulates red blood cell production) and undergoing chronic hemodialysis
Target: Healthcare Professionals (HCP)
Tagline: Reinvigorating anemia management.
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: Blood – August 13, 2009
1 views
Sep 17, 2009

Visit AdPharm.net for more pharmaceutical ads

Rise above resistance

Trisenox uses a targeted, multifunctional approach to deliver high rates of remission with minimal chemotherapy-related side effects.

Trisenox (arsenic trioxide), injectable formulation, is indicated for the treatment of induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression.

More on Medilexicon

Brand name: Trisenox
Generic name/category: arsenic trioxide, IARC Group 1 carcinogens, Antineoplastic drugs
Company: Cephalon Oncology
Country/Market: USA, North America
Indication(s)/use: acute promyelocytic leukemia (APL)
Target: Healthcare Professionals (HCP)
Tagline: Rise above resistance
Medium: Print ad
Size/duration: single-page
Publication/Aired: Blood – September 10, 2009
1 views
Sep 17, 2009

Visit AdPharm.net for more pharmaceutical ads

For patients with life-threatening fungal infections
There's no time for a second chance

Voriconazole (VFEND, Pfizer) is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections.

More on Wikipedia

Brand name: Vfend
Generic name/category: Voriconazole, Antifungals, Triazoles
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: invasive fungal infections, candidiasis, aspergillosis, and certain emerging fungal infections.
Target: Healthcare Professionals (HCP)
Tagline: When it matters most
Medium: Print ad
Size/duration: single-page
Publication/Aired: Blood – August 20, 2009

To see all of this brand's ads on AdPharm, click here
1 views
Sep 17, 2009

Visit AdPharm.net for more pharmaceutical ads

In Pulmonary arterial hypertension (PAH) WHO Class III or IV
Tracleer stands alone

Bosentan (BOZENTAN) is a dual endothelin receptor antagonist important in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States, the European Union and other countries by Actelion Pharmaceuticals for the management of PAH under the trade name Tracleer.

More on Wikipedia

Brand name: Tracleer
Generic name/category: Bosentan, Endothelin receptor antagonists
Company: Actelion
Country/Market: USA, North America
Indication(s)/use: Pulmonary arterial hypertension (PAH)
Target: Healthcare Professionals (HCP)
Tagline: A cornerstone of oral therapy
Medium: Print ad
Size/duration: single-page
Publication/Aired: Chest – September 2009

To see all of this brand's ads on AdPharm, click here
1 views
Sep 19, 2009

Visit AdPharm.net for more pharmaceutical ads

In Pulmonary arterial hypertension (PAH) WHO Class III or IV
Tracleer goes beyond symptomatic relief

Bosentan (BOZENTAN) is a dual endothelin receptor antagonist important in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States, the European Union and other countries by Actelion Pharmaceuticals for the management of PAH under the trade name Tracleer.

More on Wikipedia

Brand name: Tracleer
Generic name/category: Bosentan, Endothelin receptor antagonists
Company: Actelion
Country/Market: USA, North America
Indication(s)/use: Pulmonary arterial hypertension (PAH)
Target: Healthcare Professionals (HCP)
Tagline: A cornerstone of oral therapy
Medium: Print ad
Size/duration: single-page
Publication/Aired: Chest – August 2009

To see all of this brand's ads on AdPharm, click here
2 views
Sep 19, 2009

Visit AdPharm.net for more pharmaceutical ads

When a cold makes baby feel blue,
Sammy knows just what to do.
Make sure they're getting lots to drink.
Easy enough, now don't you think?

Tylenol is a North American brand of drugs for relieving pain, reducing fever, and relieving the symptoms of allergies, cold, cough, and flu. The active ingredient of its original, flagship product, acetaminophen (called “paracetamol” outside North America), is marketed as an analgesic and antipyretic. Like the words “acetaminophen” and “paracetamol”, the brand name is derived from the chemical name for the compound, N-acetyl-para-aminophenol (APAP). The brand is owned by McNeil Consumer Healthcare.

More on Wikipedia

Brand name: Tylenol Infants
Generic name/category: Acetaminophen, Analgesics, Antipyretics
Company: McNeil PPC, a division of Johnson & Johnson
Country/Market: USA, North America
Indication(s)/use: Cold, aches, fever
Target: Consumers (DTC)
Tagline: Feel better
Medium: Print ad
Size/duration: single-page
Publication/Aired: Parents – October 2009

To see all of this brand's ads on AdPharm, click here
1 views
Sep 16, 2009

Visit AdPharm.net for more pharmaceutical ads